RIILLO, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 245
EU - Europa 212
AS - Asia 13
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 474
Nazione #
US - Stati Uniti d'America 240
IT - Italia 144
GB - Regno Unito 22
NL - Olanda 10
SE - Svezia 9
DE - Germania 7
FR - Francia 7
CA - Canada 5
IN - India 5
RU - Federazione Russa 4
CN - Cina 3
ES - Italia 3
FI - Finlandia 3
EU - Europa 2
HK - Hong Kong 2
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
GR - Grecia 1
IR - Iran 1
SG - Singapore 1
UA - Ucraina 1
Totale 474
Città #
Chandler 56
Chicago 26
London 20
Ashburn 17
Catanzaro 13
Lawrence 12
Princeton 12
Naples 7
Santo Stefano di Rogliano 7
Melito di Porto Salvo 6
Meppel 5
Ottawa 5
Rome 5
Cosenza 4
Des Moines 4
Castrovillari 3
Hanover 3
Helsinki 3
Oristano 3
Paola 3
Redmond 3
San Antonio 3
Agrigento 2
Ahmedabad 2
Boardman 2
Bologna 2
Brescia 2
Campobello di Licata 2
Ceglie Del Campo 2
Delhi 2
Fayetteville 2
Hong Kong 2
Los Angeles 2
New York 2
Paris 2
Romainville 2
Saint-Fons 2
Serra San Bruno 2
Settingiano 2
Washington 2
Wilmington 2
Ann Arbor 1
Arnhem 1
Belovo 1
Buffalo 1
Candiolo 1
Catania 1
Clearwater 1
Decollatura 1
Delta Junction 1
Frankfurt am Main 1
Hyderabad 1
Kansas City 1
Lamezia Terme 1
Madrid 1
Melito di Napoli 1
Milan 1
Pachino 1
Phoenix 1
Seattle 1
Singapore 1
Soverato Marina 1
Squillace 1
St Petersburg 1
Vigevano 1
Totale 282
Nome #
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells 51
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 48
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 39
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 39
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 35
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 32
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 30
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 29
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 27
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 25
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 25
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 21
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 20
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 20
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 19
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 18
Alternative non-homologous end-joining: Error-prone dna repair as cancer’s achilles’ heel 17
The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives 13
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 12
Totale 520
Categoria #
all - tutte 4.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 1 0 0 0 0 0 0 3 7
2020/202150 8 0 0 6 15 0 2 5 8 6 0 0
2021/202275 1 0 0 10 4 1 7 7 21 17 6 1
2022/2023227 30 17 10 9 22 18 3 10 32 28 45 3
2023/2024157 51 16 14 12 8 38 5 8 0 4 1 0
Totale 520